Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
11. Juli 2024 08:00 ET
|
Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards
13. März 2024 09:30 ET
|
Rentschler Biopharma SE
Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
19. September 2023 05:00 ET
|
Rentschler Biopharma SE
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...
Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award
27. April 2023 10:00 ET
|
Rentschler Biopharma SE
Company presented with Workforce Development Award, recognizing partnership with MassBioEd and WPI to train people for biotech manufacturing positions Company honored at Worcester Business Journal...
Rentschler implements innovative learning program in collaboration with MassBioEd and WPI
07. Dezember 2022 09:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
18. August 2022 09:03 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Milford Companies Sells Pipeline Construction Division to Bull Creek Pipeline Services
01. Dezember 2021 11:00 ET
|
The Milford Companies
MIDLAND, Texas, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Milford Companies announced today that it has entered into a definitive agreement to sell its pipeline construction division to Bull Creek Pipeline...
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
12. August 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities
23. Juni 2021 03:30 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation...
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
31. März 2021 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...